Drugs / Irradiated haploidentical allogeneic lymphocytes
Irradiated haploidentical allogeneic lymphocytes
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00996359 | Oct 2009 → Nov 2011 | leukemia, myelodysplastic syndrome, plasma cell neoplasm | University of Medicine and Dentistry of New Jersey | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Irradiated haploidentical allogeneic lymphocytes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00996359 ↗ |
| Modality | Cell therapy | “haploidentical allogeneic cellular therapy” NCT00996359 ↗ |